NOVARTIS AG

NOVN
Delayed Quote. Delayed  - 11/26 11:31:16 am
74.72CHF -2.42%

Turn to zoom
Prev.76.5700
Open75.1400
High75.4300
Low74.4300
Volume4 805 409
Latest news
14h ago
16h ago
16h ago
16h ago
Chart NOVARTIS AG
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance76,580,580,3
Spread/Res.-2,3%-7,2%-7,0%
Spread/Supp.0,84%4,7%4,3%
Support74,171,471,7
Financials
Sales 2021 51 969 M - -
Net income 2021 12 189 M - -
Net Debt 2021 21 494 M - -
P/E ratio 2021 14,7x
Yield 2021 4,01%
Capitalization 181 B 181 B -
EV / Sales 2021 3,90x
EV / Sales 2022 3,65x
Nbr of Employees 108 000
Free-Float 85,7%
Company
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-11-30 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 80,94 $
Average target price 101,07 $
Spread / Average Target 24,9%